Serum levels of lamotrigine during delivery in mothers and their infants

被引:19
|
作者
Kacirova, Ivana [1 ]
Grundmann, Milan
Brozmanova, Hana
机构
[1] Univ Ostrava, Univ Hosp Ostrava, Fac Med, Dept Clin Pharmacol, CZ-70852 Ostrava, Czech Republic
关键词
Lamotrigine; Therapeutic drug monitoring; Epilepsy; Delivery; ANTIEPILEPTIC DRUGS; HUMAN PLACENTA; PREGNANCY; PHARMACOKINETICS; LOCALIZATION; EXPRESSION; CLEARANCE; LACTATION;
D O I
10.1016/j.eplepsyres.2010.07.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We followed up lamotrigine transport through the placenta and analyzed maternal and umibilical cord concentrations, its ratio and maternal lamotrigine clearance in monotherapy and in combinations. Methods: Maternal and umbilical cord concentrations were analyzed during delivery in a cohort of 63 women between 2001 and 2009. The request forms for routine therapeutic drug monitoring were used as the data source. Maternal concentrations were used for the estimation of apparent oral clearance and paired infant and maternal concentrations for estimation of the infant (umibilical cord)/maternal serum concentration ratio. Results: The lamotrigine infant/maternal serum concentration ratio ranged in monotherapy from 0.40 to 1.38 (median 0.91). The ratio in monotherapy showed a possible distribution to two subgroups. Concomitant administration of valproic acid significantly increased both maternal and infant lamotrigine concentrations and significantly decreased lamotrigine clearance by about 65%. Co-medication with carbamazepine increased lamotrigine clearance non-significantly. Highly significant correlations were found between maternal and umbilical cord lamotrigine concentrations, both in monotherapy and in the lamotrigine + valproic acid combination. Infant concentrations of valproic acid were found to be about 30% higher and infant concentrations of carbamazepine were found to be about 20% lower than maternal concentrations. Conclusions: Our data from the large cohort showed the interindividual variability of umbilical cord/maternal serum concentration ratio in lamotrigine monotherapy caused probably by the different activity of the placental lamotrigine metabolizing enzymes UGT1A4 and 2B7 associated with genetic polymorphism. The potential teratogenic effect of lamotrigine combination with valproic acid could be associated with the higher lamotrigine and valproic acid concentrations in the fetus. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
  • [31] Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
    Mari, Luisa
    Placidi, Fabio
    Romigi, Andrea
    Tombini, Mario
    Del Bianco, Chiara
    Ulivi, Martina
    Liguori, Claudio
    Manfredi, Natalia
    Castelli, Alessandro
    Mercuri, Nicola Biagio
    Izzi, Francesca
    NEUROLOGICAL SCIENCES, 2022, 43 (03) : 1993 - 2001
  • [32] Correlation of lamotrigine concentrations between serum and saliva
    Ryan, M
    Grim, SA
    Miles, MV
    Tang, PH
    Fakhoury, TA
    Strawsburg, RH
    deGrauw, TJ
    Baumann, RJ
    PHARMACOTHERAPY, 2003, 23 (12): : 1550 - 1557
  • [33] Lamotrigine plasma levels reduced by oral contraceptives
    Sabers, A
    Buchholt, JM
    Uldall, P
    Hansen, EL
    EPILEPSY RESEARCH, 2001, 47 (1-2) : 151 - 154
  • [34] Empiric dosing strategies to predict lamotrigine concentrations during pregnancy
    Barry, Jessica M.
    French, Jacqueline A.
    Pennell, Page B.
    Karanam, Ashwin
    Harden, Cynthia L.
    Birnbaum, Angela K.
    PHARMACOTHERAPY, 2023, 43 (10): : 998 - 1006
  • [35] Investigation of NO Levels in Depressed and Healthy Mothers, A Fetal Cord Study During the Delivery
    Camkurt, Mehmet Akif
    Findikli, Ebru
    Karaaslan, Mehmet Fatih
    Tolun, Fatma
    Bakacak, Murat
    Gunes, Serkan
    Dagli, Hasan
    Tuman, Taha Can
    JOURNAL OF MOOD DISORDERS, 2016, 6 (02) : 49 - 53
  • [36] Brivaracetam and topiramate serum levels during pregnancy and delivery: a case report and a review of literature
    Wiebke Hahn
    Leona Möller
    Katja Menzler
    Tobias Poeplau
    Uwe Wagner
    Susanne Knake
    Neurological Research and Practice, 6
  • [37] Zonisamide serum concentrations during pregnancy
    Reimers, Arne
    Helde, Grethe
    Andersen, Noemi Becser
    Aurlien, Dag
    Navjord, Elisabeth Surlien
    Haggag, Kathrine
    Christensen, Jakob
    Lillestolen, Kari Mette
    Nakken, Karl Otto
    Brodtkorb, Eylert
    EPILEPSY RESEARCH, 2018, 144 : 25 - 29
  • [38] Melatonin Levels in Preterm and Term Infants and Their Mothers
    Biran, Valerie
    Decobert, Fabrice
    Bednarek, Nathalie
    Boizeau, Priscilla
    Benoist, Jean-Francois
    Claustrat, Bruno
    Barre, Jerome
    Colella, Marina
    Frerot, Alice
    Garnotel, Roselyne
    Graesslin, Olivier
    Haddad, Bassam
    Launay, Jean-Marie
    Schmitz, Thomas
    Schroedt, Julien
    Virlouvet, Anne-Laure
    Guilmin-Crepon, Sophie
    Yacoubi, Adyla
    Jacqz-Aigrain, Evelyne
    Gressens, Pierre
    Alberti, Corinne
    Baud, Olivier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [39] Is there a ceiling lamotrigine serum level in epileptic children in remission?
    Charfi, Rim
    Gaies, Emna
    Ben Sassi, Mouna
    El Jebari, Hanene
    Kammoun, Rania
    Dahmene, Israa
    Jebabli, Nadia
    Salouage, Issam
    Daghfous, Riadh
    Trabelsi, Sameh
    THERAPIE, 2022, 77 (04): : 461 - 466
  • [40] Lamotrigine pharmacokinetics during anticonception and pregnancy
    Sabers, A.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (05) : 321 - 322